In Vitro Diagnostics Market to Reach $94.57 billion with 6.3% CAGR Forecast to 2022

PUNE, INDIA, July 25, 2016 /EINPresswire.com/ -- According to RESEARCH, the Global In Vitro Diagnostics market is accounted for $61.65 billion in 2015 and is expected to reach $94.57 billion by 2022 growing at a CAGR of 6.3%. Technologically advanced healthcare and consumer spending in market is helping the market growth. Polluted environment and contaminated surroundings are leading to increase in number of chronic disease and infections, these all factors are favoring the market to grow. Moreover widely spread knowledge and cost effectiveness are also driving the market. But stringent regulations and reimbursement issues are hampering the market growth.

Complete report details @ https://www.wiseguyreports.com/reports/562734-in-vitro-diagnostics-global-market-outlook-2015-2022

However Infectious disease in application segment is anticipated to grow at considerable pace due to rise in amount of infectious diseases and it is followed by HIV/AIDS application. Whereas Laboratories in end-user segment is estimated to grow fast because of rise in number of laboratories, followed by Point of Care Diagnostics. North America being the largest revenue market, Asia Pacific is expected to grow fast due to increasing number of End-User applications.
Some of the major key players in the market are Roche Diagnostics Bio-Rad Laboratories, Inc., Johnson and Johnson , Biomérieux, Siemens Healthcare, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Cepheid Inc , Alere Inc., Novartis and Leica Biosystems.

Request a sample report @ https://www.wiseguyreports.com/sample-request/562734-in-vitro-diagnostics-global-market-outlook-2015-2022

Applications Covered:
• Diabetes
• Autoimmune Diseases
• Cardiology
• Drug Testing
• HIV/AIDS
• Infectious Diseases
• Nephrology
• Oncology/Cancer
• Other Applications
Product & Services Covered:
• Data Management Software/Hardware
• Instruments
• Reagents & Kits
• Services
Technologies Covered:
• Immunochemistry/Immunoassays
o Elisa
 Chemiluminescence Immunoassays (CLIAs)
 Colorimetric Immunoassays (CI)
 Fluorescence Immunoassays (FIA)
o Western Blot
o Rapid Tests
o Radioimmunoassay’s (RIA)
o Elispot
• Coagulation and Hemostasis
• Molecular Diagnostics (MDX)
o DNA Sequencing & Next-Generation Sequencing
o Hybridization
o Isothermal Nucleic Acid Amplification Technology (INAAT)
o Microarrays
o Polymerase Chain Reaction (PCR)
o Other Molecular Diagnostics
• Hematology
• Microbiology
• Clinical Chemistry
o Electrolyte Panels
o Basic Metabolic Panel
o Lipid Profiles
o Liver Panels
o Renal Profiles
o Specialty Chemical Tests
o Thyroid Function Panels
• Other Technologies
End-Users Covered:
• Academic Institutes
• Hospitals
• Laboratories
• Patient Self-Testing
• Point-Of-Care Testing
• Other End-Users
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/562734-in-vitro-diagnostics-global-market-outlook-2015-2022

Table of content
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Technology Analysis
3.9 End-User Analysis
3.10 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global In Vitro Diagnostics Market, By Application
5.1 Introduction
5.2 Diabetes
5.3 Autoimmune Diseases
5.4 Cardiology
5.5 Drug Testing
5.6 HIV/AIDS
5.7 Infectious Diseases
5.8 Nephrology
5.9 Oncology/Cancer
5.10 Other Applications

6 Global In Vitro Diagnostics Market, By Product & Service
6.1 Introduction
6.2 Data Management Software/Hardware
6.3 Instruments
6.4 Reagents & Kits
6.5 Services

7 Global In Vitro Diagnostics Market, By Technology
7.1 Introduction
7.2 Immunochemistry/Immunoassays
7.2.1 Elisa
7.2.1.1 Chemiluminescence Immunoassays (CLIAs)
7.2.1.2 Colorimetric Immunoassays (CI)
7.2.1.3 Fluorescence Immunoassays (FIA)
7.2.2 Western Blot
7.2.3 Rapid Tests
7.2.4 Radioimmunoassays (RIA)
7.2.5 Elispot
7.3 Coagulation and Hemostasis
7.4 Molecular Diagnostics (MDX)
7.4.1 DNA Sequencing & Next-Generation Sequencing
7.4.2 Hybridization
7.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4.4 Microarrays
7.4.5 Polymerase Chain Reaction (PCR)
7.4.6 Other Molecular Diagnostics
7.5 Hematology
7.6 Microbiology
7.7 Clinical Chemistry
7.7.1 Electrolyte Panels
7.7.2 Basic Metabolic Panel
7.7.3 Lipid Profiles
7.7.4 Liver Panels
7.7.5 Renal Profiles
7.7.6 Specialty Chemical Tests
7.7.7 Thyroid Function Panels
7.8 Other Technologies

8 Global In Vitro Diagnostics Market, By End-User
8.1 Introduction
8.2 Academic Institutes
8.3 Hospitals
8.4 Laboratories
8.5 Patient Self-Testing
8.6 Point-Of-Care Testing
8.7 Other End-Users

9 Global In Vitro Diagnostics Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Roche Diagnostics
11.2 Bio-Rad Laboratories, Inc.
11.3 Johnson and Johnson
11.4 Biomérieux
11.5 Siemens Healthcare
11.6 Abbott Laboratories, Inc.
11.7 Thermo Fisher Scientific, Inc.
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Danaher Corporation
11.10 Sysmex Corporation
11.11 Becton, Dickinson and Company
11.12 Cepheid Inc
11.13 Alere Inc.
11.14 Novartis
11.15 Leica Biosystems

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=562734

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.